Merck & Company Inc
MRK
$145.35-1.37%
End of day · as of Oct 15, 2026, 5:17 PM ET
Mkt cap
$285.12B
EV/Sales
4.92
P/E ratio
116.3
FY2025 Revenue
$65.01B
EPS (TTM)
$1.25
Gross Margin (FY2025)
74.80%
Profit Margin (FY2025)
28.08%
Beta
N/A
Div yield
2.85%
Sector
Healthcare
Merck & Company Inc (MRK) is a drug manufacturers - general company listed on NYSE. It is led by Robert M. Davis J.D..
Latest reported MRK revenue for 2025-12-31 was $65.01B. Net income was $18.25B. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. MRK currently screens at market cap $285.12B and trailing P/E 116.3.
Use this MRK research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full MRK income, balance, and cash tables.
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
Merck & Company Inc (MRK) is a drug manufacturers - general company in the Healthcare sector.
Latest cached Merck & Company Inc (MRK) revenue for Dec 31, 2025 was $65.01B. Net income was $18.25B. Statements: https://lician.com/financials/mrk
Merck & Company Inc (MRK) trailing P/E is 116.3 on the latest cached fundamentals snapshot.
Merck & Company Inc (MRK) market capitalization is $285.12B on the latest cached snapshot.
Merck & Company Inc (MRK) cached previous close $147.37; day range $144.90 – $149.90; volume 13,827,676. Session quote: https://lician.com/quote/mrk
Merck & Company Inc (MRK) latest cached earnings event is "MRK earnings" on Oct 29, 2026. Earnings calendar: https://lician.com/earnings
The latest cached MRK filing is 8-K · Oct 13, 2026. Filings: https://lician.com/sec/mrk